Agenus
AGEN
$6.46
Share price
11.96%
Change (1 day)
271.26%
Change (1 year)
Categories
Agenus (AGEN) - Cash on Hand
Cash on Hand as of December 2023 : $76.11 M
According to Agenus
's latest financial reports the company has $76.11 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Agenus - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $76.11 M | -60.64% |
| 2022-12-31 | $0.19 B | -37% |
| 2021-12-31 | $0.30 B | 207.32% |
| 2020-12-31 | $99.87 M | 61.58% |
| 2019-12-31 | $61.8 M | 16.5% |
| 2018-12-31 | $53.05 M | -11.85% |
| 2017-12-31 | $60.18 M | -21.26% |
| 2016-12-31 | $76.43 M | -55.47% |
| 2015-12-31 | $0.17 B | 326.78% |
| 2014-12-31 | $40.22 M | 47.06% |
| 2013-12-31 | $27.35 M | 27.41% |
| 2012-12-31 | $21.46 M | 99.74% |
| 2011-12-31 | $10.74 M | -45.67% |
| 2010-12-31 | $19.78 M | -34.2% |
| 2009-12-31 | $30.06 M | -12.76% |
| 2008-12-31 | $34.46 M | 84.5% |
| 2007-12-31 | $18.67 M | -53.41% |
| 2006-12-31 | $40.09 M | -35.07% |
| 2005-12-31 | $61.74 M | -28.96% |
| 2004-12-31 | $86.92 M | -2.86% |
| 2003-12-31 | $89.47 M | 52.37% |
| 2002-12-31 | $58.72 M | -3.52% |
| 2001-12-31 | $60.86 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 30,023.51% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 9,219.41% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 16,034.54% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 8,249.52% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | $0.42 B | 456.56% | 🇺🇸 USA |